1. Home
  2. PATK vs MIRM Comparison

PATK vs MIRM Comparison

Compare PATK & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PATK
  • MIRM
  • Stock Information
  • Founded
  • PATK 1959
  • MIRM 2018
  • Country
  • PATK United States
  • MIRM United States
  • Employees
  • PATK N/A
  • MIRM N/A
  • Industry
  • PATK Auto Parts:O.E.M.
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PATK Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • PATK Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • PATK 3.2B
  • MIRM 3.8B
  • IPO Year
  • PATK N/A
  • MIRM 2019
  • Fundamental
  • Price
  • PATK $99.34
  • MIRM $68.70
  • Analyst Decision
  • PATK Buy
  • MIRM Strong Buy
  • Analyst Count
  • PATK 10
  • MIRM 11
  • Target Price
  • PATK $105.40
  • MIRM $79.00
  • AVG Volume (30 Days)
  • PATK 213.3K
  • MIRM 728.1K
  • Earning Date
  • PATK 10-30-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • PATK 1.62%
  • MIRM N/A
  • EPS Growth
  • PATK N/A
  • MIRM N/A
  • EPS
  • PATK 3.69
  • MIRM N/A
  • Revenue
  • PATK $3,816,541,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • PATK $3.72
  • MIRM $53.14
  • Revenue Next Year
  • PATK $5.73
  • MIRM $19.83
  • P/E Ratio
  • PATK $26.82
  • MIRM N/A
  • Revenue Growth
  • PATK 6.09
  • MIRM 62.33
  • 52 Week Low
  • PATK $72.99
  • MIRM $36.88
  • 52 Week High
  • PATK $116.78
  • MIRM $78.55
  • Technical
  • Relative Strength Index (RSI)
  • PATK 42.61
  • MIRM 38.20
  • Support Level
  • PATK $95.91
  • MIRM $71.78
  • Resistance Level
  • PATK $99.94
  • MIRM $77.00
  • Average True Range (ATR)
  • PATK 2.75
  • MIRM 2.83
  • MACD
  • PATK 0.03
  • MIRM -0.60
  • Stochastic Oscillator
  • PATK 32.04
  • MIRM 14.80

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: